Luc Mertens

Luc Mertens

Auto-generated profile, based on publicly available information

Luc Mertens

Department of Pediatrics University of Toronto Toronto Canada

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2018 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
LBLuigi P. Badano
Luigi P. Badano
TKTheodore J Kolias
Theodore J Kolias
DMDenisa Muraru
Denisa Muraru
TATheodore P Abraham
Theodore P Abraham
GAGerard Aurigemma
Gerard Aurigemma
LSLeyla Elif Sade
Leyla Elif Sade
The EACVI/ASE/Industry Task Force to standardize deformation imaging prepared this consensus document to standardize definitions and techniques for using two-dimensional (2D) speckle tracking echocardiography (STE) to assess left atrial, right ventricular, and right atrial myocardial deformation. This document is intended for both the technical engineering community and the clinical community at large to provide guidance on selecting the functional parameters to measure and how to measure them using 2D STE. This document aims to represent a significant step forward in the collaboration between the scientific societies and the industry since technical specifications of the software packages designed to post-process echocardiographic datasets have been agreed and shared before their actual development. Hopefully, this will lead to more clinically oriented software packages which will be better tailored to clinical needs and will allow industry to save time and resources in their development.

1 May 1998 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
LMLuc Mertens
Luc Mertens
DHDonald J. Hagler
Donald J. Hagler
USUrsula Sauer
Ursula Sauer
JSJane Somerville
Jane Somerville
MGMarc Gewillig
Marc Gewillig

21 October 2016 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
PLPatrizio Lancellotti
Patrizio Lancellotti
PPPatricia A. Pellikka
Patricia A. Pellikka
WBWerner Budts
Werner Budts
FCFarooq A. Chaudhry
Farooq A. Chaudhry
EDErwan Donal
Erwan Donal
AVAlbert Varga
Albert Varga
A unique and highly versatile technique, stress echocardiography (SE) is increasingly recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for simultaneous assessment of myocardial function and haemodynamics under physiological or pharmacological conditions. Due to its diagnostic and prognostic value, SE has become widely implemented to assess various conditions other than ischaemic heart disease. It has thus become essential to establish guidance for its applications and performance in the area of non-ischaemic heart disease. This paper summarizes these recommendations.

5 November 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
FAFrédéric Amant
Frédéric Amant
TVTineke Vandenbroucke
Tineke Vandenbroucke
MVMagali Verheecke
Magali Verheecke
MFMonica Fumagalli
Monica Fumagalli
MHMichael J. Halaska
Michael J. Halaska
KCKristel Van Calsteren
Kristel Van Calsteren
Data on the long-term outcome of children who are exposed to maternal cancer with or without treatment during pregnancy are lacking. In this multicenter case–control study, we compared children whose mothers received a diagnosis of cancer during the pregnancy with matched children of women without a cancer diagnosis. We used a health questionnaire and medical files to collect data regarding neonatal and general health. All children were prospectively assessed (by means of a neurologic examination and the Bayley Scales of Infant Development) at 18 months, 36 months, or both. A cardiac assessment was performed at 36 months. A total of 129 children (median age, 22 months; range, 12 to 42) were included in the group whose mother had cancer (prenatal-exposure group) with a matching number in the control group. During pregnancy, 96 children (74.4%) were exposed to chemotherapy (alone or in combination with other treatments), 11 (8.5%) to radiotherapy (alone or in combination), 13 (10.1%) to surgery alone, 2 (1.6%) to other drug treatments, and 14 (10.9%) to no treatment. Birth weight was below the 10th percentile in 28 of 127 children (22.0%) in the prenatal-exposure group and in 19 of 125 children (15.2%) in the control group (P=0.16). There was no significant between-group difference in cognitive development on the basis of the Bayley score (P=0.08) or in subgroup analyses. The gestational age at birth was correlated with the cognitive outcome in the two study groups. Cardiologic evaluation among 47 children at 36 months of age showed normal cardiac findings. Prenatal exposure to maternal cancer with or without treatment did not impair the cognitive, cardiac, or general development of children in early childhood. Prematurity was correlated with a worse cognitive outcome, but this effect was independent of cancer treatment. (Funded by Research Foundation–Flanders and others; ClinicalTrials.gov number, NCT00330447.)

1 October 2011 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
LMLuc Mertens
Luc Mertens
ISIstvan Seri
Istvan Seri
JMJan Marek
Jan Marek
RARomaine Arlettaz
Romaine Arlettaz
PBPiers Barker
Piers Barker
WLWyman W. Lai
Wyman W. Lai

1 September 2014 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
RKRichard Kirk
Richard Kirk
ADAnne I. Dipchand
Anne I. Dipchand
DRDavid N. Rosenthal
David N. Rosenthal
LALinda Addonizio
Linda Addonizio
MBMichael Burch
Michael Burch
RWRobert Weintraub
Robert Weintraub